PATENT CLAIM ANALYSIS

Application Number: 16148976
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-06
Patent Classification: ["514", "331000"]

Abstract:
Provided herein are compositions for preventing or treating muscle conditions such as muscle damage, injury, or atrophy. In some embodiments, the compositions comprise a prostaglandin E2 (PGE2) compound and a myotoxin. In some embodiments, the muscle damage, injury, or atrophy is the result of a nerve injury, a surgical procedure, or a traumatic injury. Methods of promoting muscle regeneration and methods of increasing muscle mass are also provided herein.

Claim (Index 10):
The method of  claim 9 , wherein the amino-ester anesthetic is an aminobenzoic acid ester anesthetic, and the aminobenzoic acid ester anesthetic is selected from the group consisting of benzocaine, butacaine, butamben, chloroprocaine, dimethocaine, lucaine, meprylcaine, metabutethamine, metabutoxycaine, nitracaine, orthocaine, propoxycaine, procaine, proxymetacaine, risocaine, tetracaine, and a combination thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 97.0
- Lexical Diversity: 1.80435
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15891278', '16022578', '13836794', '13838002', '14783426']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7919794164110613
- 35 USC 102 Novelty (BERT): 0.5993632536835586
- Combined Prediction Score: 0.772717800138311
- Mean Citation Score: 315.679646
- Max Citation Score: 586.6288
- Similarity Product: 437.90529597578046

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test